On Demand Webinars on Protein Sequencing - Rapid Novor

WebinarsBrad Anthony2023-02-16T10:57:06-05:00

Rational Antibody Design and Engineering with Next Generation Protein Sequencing

Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Webinar

Rational Antibody Design and Engineering with Next Generation Protein Sequencing

June 15

11 AM EDT / 9 AM MDT

Discover the latest webinars.

The Shortcut to Reliable Diagnostic, Control, and Assay Antibodies

Illia icherednychenko@rapidnovor.com2023-05-15T12:41:55-04:00Tags: Application, De novo sequencing, Featured, Learning, Monoclonal antibody, Polyclonal antibody, Recombinant expression, REmAb, REpAb|

Navigating Intellectual Property Protection for Antibodies

Illia icherednychenko@rapidnovor.com2023-05-15T10:45:03-04:00Tags: Antibody characterization, Antibody kinetics, Application, Featured, HDX-MS, Monoclonal antibody, REmAb, SPR|

Nanobody Lead Optimization with Epitope Mapping and Binning

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:14-04:00Tags: Alpaca, Antibody characterization, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Selecting Specific Monoclonal Antibodies by SPR – Alpaca Antibody Showdown

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:34-04:00Tags: Alpaca, Antibody characterization, Antibody discovery, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Characterizing Fragile Protein Complexes

Illia icherednychenko@rapidnovor.com2023-05-15T12:45:26-04:00Tags: Antibody characterization, Application, De novo sequencing, Featured, Monoclonal antibody, Proteomics, REmAb, Technology|

Next Generation Vaccine Development with Proteomics

Illia icherednychenko@rapidnovor.com2023-05-15T12:46:29-04:00Tags: Antibody characterization, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Featured, Monoclonal antibody, Proteomics, REmAb, Technology|

Enriching Engineered T Cells with Antibody Sequencing & Modulation

Illia icherednychenko@rapidnovor.com2023-05-15T12:48:13-04:00Tags: Antibody characterization, Antibody engineering, Application, De novo sequencing, Monoclonal antibody, Proteomics, REmAb, Technology|

Breakthrough Bispecific Antibody R&D Techniques

Illia icherednychenko@rapidnovor.com2023-05-15T12:49:14-04:00Tags: Antibody characterization, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb|

Species-Agnostic Antibody Sequencing & Discovery in Veterinary Medicine R&D

Illia icherednychenko@rapidnovor.com2023-05-15T12:51:44-04:00Tags: Antibody characterization, Antibody discovery, Antibody engineering, Antibody therapeutics, Application, De novo sequencing, Proteomics, REmAb, Technology, Vet med|

Why Antibody Characterization Needs an Overhaul

Illia icherednychenko@rapidnovor.com2023-05-15T12:51:17-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REmAb|

Leveraging the Power of Next Generation Protein Sequencing to Shape Tomorrow’s In Vitro Diagnostics

Illia icherednychenko@rapidnovor.com2023-05-15T12:53:59-04:00Tags: Antibody characterization, Application, De novo sequencing, Monoclonal antibody, Proteomics, REmAb, Technology|

Why Is Sequence Blindness Acceptable with Antibodies?

Illia icherednychenko@rapidnovor.com2023-05-15T12:54:56-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, Technology|

Recombinant Therapeutic pAbs are Now Possible

Illia icherednychenko@rapidnovor.com2023-05-15T12:55:49-04:00Tags: Antibody characterization, Antibody engineering, De novo sequencing, Learning, Proteomics, Recombinant expression, REmAb, Technology|

Polyclonal Antibody Sequencing in Therapeutics Development Pipelines

Illia icherednychenko@rapidnovor.com2023-05-15T12:56:54-04:00Tags: Antibody characterization, Antibody discovery, Antibody engineering, Application, De novo sequencing, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Overcoming Irreproducibility in Life Science Research

Illia icherednychenko@rapidnovor.com2023-05-15T12:57:47-04:00Tags: Antibody characterization, Antibody engineering, De novo sequencing, Learning, Monoclonal antibody, Proteomics, Recombinant expression, REmAb, Technology|

Fully Harnessing the Power of Immunotherapy through Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-05-15T12:58:22-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

DNA vs Next Generation Protein Sequencing – a Deep Dive

Illia icherednychenko@rapidnovor.com2023-05-15T12:59:06-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

Polyclonal Antibody Sequencing with Only Proteomics

Illia icherednychenko@rapidnovor.com2023-05-15T13:00:24-04:00Tags: Antibody characterization, Antibody discovery, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Non-Fungible Antibodies

Illia icherednychenko@rapidnovor.com2023-05-15T13:01:17-04:00Tags: Antibody characterization, De novo sequencing, Learning, Proteomics, Recombinant expression, REmAb, Technology|

Leveraging pAbs for Therapeutic Development

Illia icherednychenko@rapidnovor.com2023-05-15T13:02:23-04:00Tags: Antibody characterization, Antibody discovery, Antibody therapeutics, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Leveraging Polyclonal Antibody Sequencing to Get High Affinity Binders Against Tough Targets

Illia icherednychenko@rapidnovor.com2023-05-15T13:04:28-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Antibody Sequencing as a Tool to Improve Reproducibility in the Life Sciences

Illia icherednychenko@rapidnovor.com2023-05-15T13:12:00-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

New Era in Anti-Drug Antibody Assays

Illia icherednychenko@rapidnovor.com2023-05-15T13:12:58-04:00Tags: Antibody characterization, Application, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb|

Research Insurance with De Novo Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-05-15T13:13:48-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

All Things Proteomics Newsletter.

All Posts.

Tackling Reproducibility in Life Sciences with Next Generation Protein Sequencing and Recombinant Expression

Genya Gorshtein2023-06-02T10:38:42-04:00Categories: Articles|Tags: General knowledge, Protein sequencing, Recombinant expression, REmAb, REpAb|

Rational Antibody Design and Engineering with Next Generation Protein Sequencing

Illia icherednychenko@rapidnovor.com2023-05-15T12:41:13-04:00Categories: Webinars|Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb, Technology|

Evaluation and Selection of a Lead Diabody for Interferon-γ PET Imaging

Vanessa Yoon Calvelo2023-05-15T10:38:06-04:00Categories: Case Studies|Tags: Antibody engineering, Antibody generation, Application, De novo sequencing, Featured, Monoclonal antibody, Recombinant expression, REmAb|

Functional Characterization of Therapeutic Antibodies

Vanessa Yoon Calvelo2023-05-15T11:02:52-04:00Categories: Articles|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Learning, Monoclonal antibody, Proteomics, REmAb, SPR|

Secure Full Antibody and Target IP Protection with Next Generation Protein Sequencing

Genya Gorshtein2023-05-25T10:18:05-04:00Categories: Articles|Tags: Application, De novo sequencing, HDX-MS, SPR|

Immunochemical Characterization of Therapeutic Antibodies

Vanessa Yoon Calvelo2023-05-15T11:03:29-04:00Categories: Articles|Tags: Antibody characterization, De novo sequencing, Featured, HDX-MS, Learning, Monoclonal antibody, Proteomics, SPR|

The Shortcut to Reliable Diagnostic, Control, and Assay Antibodies

Illia icherednychenko@rapidnovor.com2023-05-15T12:41:55-04:00Categories: Webinars|Tags: Application, De novo sequencing, Featured, Learning, Monoclonal antibody, Polyclonal antibody, Recombinant expression, REmAb, REpAb|

Exploring the Sheep (Ovis aries) Immunoglobulin Repertoire by Next Generation Sequencing

Vanessa Yoon Calvelo2023-05-15T12:18:07-04:00Categories: Case Studies|Tags: Antibody discovery, Application, Featured, Monoclonal antibody, Next-generation sequencing, Polyclonal antibody, Sheep, Technology, Vet med|

Navigating Intellectual Property Protection for Antibodies

Illia icherednychenko@rapidnovor.com2023-05-15T10:45:03-04:00Categories: Webinars|Tags: Antibody characterization, Antibody kinetics, Application, Featured, HDX-MS, Monoclonal antibody, REmAb, SPR|

Therapeutic Antibody Discovery: From Target to Candidate

Genya Gorshtein2023-05-25T10:19:37-04:00Categories: Articles|Tags: Antibody characterization, Antibody therapeutics, Application, General knowledge, Therapeutic Antibody Discovery|

Nanobody Lead Optimization with Epitope Mapping and Binning

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:14-04:00Categories: Webinars|Tags: Alpaca, Antibody characterization, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Towards Antigen-Specific Tregs for Type 1 Diabetes: Construction and Functional Assessment of Pancreatic Endocrine Marker, HPi2-Based Chimeric Antigen Receptor

Vanessa Yoon Calvelo2023-05-15T12:03:29-04:00Categories: Case Studies|Tags: Antibody characterization, Antibody engineering, Application, De novo sequencing, Featured, Monoclonal antibody, REmAb|

Antibody Affinity and Avidity – The Strength of a Single Interaction Versus a Multivalent Interaction

Genya Gorshtein2023-05-25T10:20:23-04:00Categories: Articles|Tags: Antibody characterization, Binding kinetics, General knowledge, Learning, Protein characterization, Sensorgram, SPR, Surface plasmon resonance|

Technologies for Antibody Discovery and Generation

Vanessa Yoon Calvelo2023-05-15T11:08:02-04:00Categories: Articles|Tags: Antibody discovery, Antibody generation, Featured, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

The Hunt for Novel Therapeutics Through Antibody Engineering

Genya Gorshtein2023-05-25T10:28:30-04:00Categories: Articles|Tags: Antibody characterization, Antibody engineering, Antibody therapeutics, Application, General knowledge, HDX-MS, REmAb, SPR|

Cell Specific Protein Degradation with Antibody Conjugated PROTACs

Genya Gorshtein2023-05-25T10:29:24-04:00Categories: Articles|Tags: AbPROTACs, Antibody characterization, Antibody Drug Conjugates, Antibody engineering, Antibody therapeutics, Application, General knowledge, HDX-MS, pAb, SPR, Surface plasmon resonance|

Structural Characterization of Endogenous Tuberous Sclerosis Protein Complex Revealed Potential Polymeric Assembly

Vanessa Yoon Calvelo2023-05-15T12:04:02-04:00Categories: Case Studies|Tags: Antibody characterization, Antibody engineering, Application, De novo sequencing, Featured, Monoclonal antibody, REmAb|

Selecting Specific Monoclonal Antibodies by SPR – Alpaca Antibody Showdown

Illia icherednychenko@rapidnovor.com2023-05-15T12:44:34-04:00Categories: Webinars|Tags: Alpaca, Antibody characterization, Antibody discovery, Antibody kinetics, Application, Featured, Nanobody, Polyclonal antibody, REpAb, SPR, Technology, Vet med|

Resistance to Autosomal Dominant Alzheimer’s Disease in an APOE3 Christchurch Homozygote

Vanessa Yoon Calvelo2023-05-15T12:05:11-04:00Categories: Case Studies|Tags: Antibody engineering, Antibody generation, Antibody therapeutics, Application, De novo sequencing, Featured, Monoclonal antibody, REmAb|

Characterizing Biomolecular Interactions with Surface Plasmon Resonance

Vanessa Yoon Calvelo2023-05-15T11:24:31-04:00Categories: Articles|Tags: Antibody characterization, Antibody kinetics, Learning, Monoclonal antibody, Polyclonal antibody, SPR, Technology|

Antibody-Drug Conjugates as Anti-Cancer Therapeutics

Genya Gorshtein2023-05-25T10:30:00-04:00Categories: Articles|Tags: Antibody Drug Conjugates, Antibody drug discovery, Antibody engineering, Antibody therapeutics, Application, mAb, REmAb, SPR, Therapeutic Antibody Discovery|

Characterizing Fragile Protein Complexes

Illia icherednychenko@rapidnovor.com2023-05-15T12:45:26-04:00Categories: Webinars|Tags: Antibody characterization, Application, De novo sequencing, Featured, Monoclonal antibody, Proteomics, REmAb, Technology|

What Generates Antibody Diversity?

Genya Gorshtein2023-05-25T10:32:38-04:00Categories: Articles|Tags: Antibody diversity, General knowledge, Learning, Protein sequencing, REmAb, REpAb|

What are Polyclonal Antibodies?

Genya Gorshtein2023-05-25T10:36:53-04:00Categories: Articles|Tags: Antibody drug discovery, Antibody engineering, Antibody therapeutics, General knowledge, Immunotherapy, Learning, pAb, Protein characterization, REpAb, Reproducibility|

Surface Plasmon Resonance Spectroscopy

Vanessa Yoon Calvelo2023-05-15T10:54:22-04:00Categories: Articles|Tags: Antibody characterization, Antibody kinetics, Learning, Monoclonal antibody, Polyclonal antibody, SPR|

Talk to Our Scientists.

We Have Sequenced 8000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 8000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 8000 antibodies and we are eager to help you.